<!DOCTYPE html> 
 <!--[if lt IE 7]> <html lang="en" class="ie ie6 lte9 lte8 lte7 os-other"> <![endif]-->
 <!--[if IE 7]> <html lang="en" class="ie ie7 lte9 lte8 lte7 os-other"> <![endif]-->
 <!--[if IE 8]> <html lang="en" class="ie ie8 lte9 lte8 os-other"> <![endif]-->
 <!--[if IE 9]> <html lang="en" class="ie ie9 lte9 os-other"> <![endif]-->
 <!--[if gt IE 9]> <html lang="en" class="os-other"> <![endif]-->
 <!--[if !IE]><!--> <html lang="en" class="os-other"> <!--<![endif]-->

<head>


      
      
      
      
      
      
      
    



     
      
  
  

    
      
        
          
            
                
              
          
        
      
    
    


     
      
  

    
      
        
          
            
                
              
          
        
      
    
    



  <meta name="lnkd-track-json-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=2jds9coeh4w78ed9wblscv68v-eo3jgzogk6v7maxgg86f4u27d&amp;fc=2">
  <meta name="lnkd-track-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=eo3jgzogk6v7maxgg86f4u27d&amp;fc=2">




  
    <meta name="treeID" content="4Nd46Q+nJRNQtQNzuSoAAA==">
  



  <meta name="appName" content="profile">


<meta name="lnkd-track-error" content="/lite/ua/error?csrfToken=ajax%3A5300005367096190683&amp;goback=%2Enppvan_guvenckockaya">


     
      
  
  
  
  

    
      
        
          
            
                
                  
                    <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=8swqmpmjehppqzovz8zzfvv9g-aef5jooigi7oiyblwlouo8z90-e2u0uzhuvp24qrred2yekckx1-10q339fub5b718xk0pv9lzhpl&amp;fc=2"></script>
                  
                  
                
              
          
        
      
    
    



 <meta http-equiv="content-type" content="text/html; charset=UTF-8">
 <meta http-equiv="X-UA-Compatible" content="IE=8">
 <meta name="description" content="View Guvenc Kockaya, MD, MSc's professional profile on LinkedIn.  LinkedIn is the world's largest business network, helping professionals like Guvenc Kockaya, MD, MSc discover inside connections to recommended job candidates, industry experts, and business partners.">
 <meta name="pageImpressionID" content="fcf61ada-ff39-4f64-8ca4-d20793f8727b">
 <meta name="pageKey" content="nprofile-public-success" >
 <meta name="analyticsURL" content="/analytics/noauthtracker">

 
 
<link rel="apple-touch-icon-precomposed" href="/img/icon/apple-touch-icon.png">
<!--[if lte IE 8]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/16x16/favicon.ico">
<![endif]-->
<!--[if IE 9]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<![endif]-->
<link rel="icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">


<meta name="msapplication-TileImage" content="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicon_w8_tile.png"/>
<meta name="msapplication-TileColor" content="#0077B5"/>
<meta name="application-name" content="LinkedIn"/>

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 <link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=3bifs78lai5i0ndyj1ew7316e-2ls5j5cdjrujv4sqdb0z16lmh-2it1to3q1pt5evainys9ta07p-4uu2pkz5u0jch61r2nhpyyrn8-ee859529mdos6retehcmn9z8a-7poavrvxlvh0irzkbnoyoginp-4om4nn3a2z730xs82d78xj3be-4mtnezjah7m1dorg1ys1puyqz-ct4kfyj4tquup0bvqhttvymms-9zbbsrdszts09by60it4vuo3q-bjn9kbvacgrovgpk6in831zk8-8ti9u6z5f55pestwbmte40d9-9x2uxeluz13xxpss2v8op0phx-cxff0g818hf3ks7dzixd4lqcq-2d3dmhru4d3a2ekwmxrg5bwd3&amp;fc=2">
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=dfoaudjrk6rbf82f45bz5crwi-62og8s54488owngg0s7escdit-c8ha6zrgpgcni7poa5ctye7il-djim7uyllidc9gta745y2wo5m-51dv6schthjydhvcv6rxvospp-d7z5zqt26qe7ht91f8494hqx5-e9rsfv7b5gx0bk0tln31dx3sq-2r5gveucqe4lsolc3n0oljsn1-8v2hz0euzy8m1tk5d6tfrn6j-b88qxy99s08xoes3weacd08uc-bymlr3eiytxzjg9or01ze5ia8-ac8pg92mfnb2j836ntpvg1fsi-a75npl1uw7jvxtd6tpgps2gw3-lyi4ca0d33mbzhvnuf1wvqjp-80pbsa4obuk9pkni9fepx3r1u-b0otj9zjsih2zu4s3gxjejik2-8gnadkog4qjkvf7alm205sobz-3ns2d4ano7knp93wdj2zg3drz-65r02rf4fgqf3q3s7b42u1w0z-1pa3tpaab6s85oxj5wgz5m0p7&amp;fc=2"></script>
 
 
  

          
          
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

          
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 

 
 

 
 
 
 
 
 
 
 <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=6b5tomv24hymqjdn9yh9vdxyg-95d8d303rtd0n9wj4dcjbnh2c&amp;fc=2"></script>
 
 

<title>Guvenc Kockaya, MD, MSc  | LinkedIn</title>

          
        

        
      
      
      
      
        
      
    
      
        
      
    
  

  
  
    <link rel="canonical" href="http://tr.linkedin.com/in/guvenckockaya" />
  
  
     
    
    
    
    
    
		
			
			
		
    

    
      
    
  
     
      
        
          
            
                
                  
                  
                    <link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=4p2lr3v1stqdryp7cwmzusws3-bubc6rv5t8u1olw8jqdcmcsxx-2f80q3wku8xajybx85i5jg69w-5xxmkfcm1ny97biv0pwj7ch69-bh4epi2lmzdt5u7j34vbgtyn&amp;fc=2">
                  
                
              
          
        
      
    
     
  
     
      
    
    
    
    
    
    
  
    
      
        
          
            
                
                  
                    <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=alwisf9y2dgcx9durselvuryg-ew7wxbzv14lsc4vzkh2xrbzqn-dym7zp2dihe7sffiofjsa8c2n-cy4lqo5zy7pd10f5x6q2mcbav-1tcbnhkiqjn5ocajdluwwguus&amp;fc=2"></script>
                  
                  
                
              
          
        
      
    
    

      
      
      
        
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
     
      
      
     
    
      
        
          
            
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      

      
        
      


















            
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
</head>
        
      
      
      
      
        
      
    
    

  
      
      
      
        
      
    
      
        

        
          

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 

 
 

 
 







<body class="en guest v2 public-profile chrome-v5 chrome-v5-responsive background-v4 sticky-bg guest" id="pagekey-nprofile-public-success">

 
 
 
 
 
 







 <input id="inSlowConfig" type="hidden" value="false" />

<script type="text/javascript">document.body.className += " js ";</script>


          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




<div id="header">
 <div class="wrapper">
 <div id="nav-utility">
 <div class="logo" id="logo-linkedin">
 <a href="/home?trk=hb_logo" id="logo-href"><img src="http://s.c.lnkd.licdn.com/scds/common/u/img/logos/logo_linkedin_92x22.png" width="92" height="22" alt="LinkedIn"></a>
 </div>
 <ul class="menu">
 <li id="nav-utility-join"><a href="https://www.linkedin.com/reg/join?trk=hb_join">Join Today</a></li>
 <li id="nav-utility-auth"><a href="https://www.linkedin.com/uas/login?trk=hb_signin">Sign In</a></li>
 </ul>
 </div>
 </div> </div>

<div id="body">

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 

 
 

 <div class="wrapper">
 
 
 
 
 
 
 
 
 


 
 
 

 
 

<div id="global-error">
</div>




        

        
      
    
  
      
      

      
        
      



      
      
      
      
        
      
    
      
    
      

      <div id="main" class="profile grid-a">

        

        
        <div id="content" class="resume hresume">
          <div class="profile-header">
						<div id="member-1" class="masthead vcard contact">
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      




















  
  
  
      <div class="image zoomable" style="display:block" id="profile-picture">
        
            
                 <img src="http://m.c.lnkd.licdn.com/mpr/pub/image-oX1oqqNhPFc3o06gj_EuwWCzRok-jUbUVXLRS4cTRV9zxmumoX1RYT9hR58GjdwUTmm5/guvenc-kockaya-md-msc.jpg" class="photo" width="100" height="100" alt="Guvenc Kockaya, MD, MSc">
              
          
		</div>
	
  
  
      <h1>

      
        

        
            <span id="name" class="n fn">
              <span class="full-name"><span class="given-name">Guvenc</span> <span class="family-name">Kockaya, MD, MSc</span></span>
            </span>

          
          
          

      
        

      </h1>
    

  
  
    
      <span class="phonetic-full-name">
      
      </span>
    
  

  
  
    <p class="headline-title title" style="display:block">
    
    
        Sr. Healthcare Economics, Policy &amp; Reimbursement Manager at Covidien Turkey &amp; Azerbaijan
      
    
    </p>
  
  
  
       
     
  
  <dl id="headline" class="demographic-info adr">
    <dt>Location</dt>
    <dd>
    <span class="locality">
    
        
          
	      Ankara, Turkey
            
	    
      
    </span>
    
    </dd>
    
    <dt>Industry</dt>
        <dd class="industry">
    
            Medical Devices
      
    </dd>
    
  </dl>
  
       
     
      












            </div>
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


      
    
  
      
      

      
        
      











<div id="nprofile-overview" class="join-linkedin name-button">
  <div class="header">

    <h2>
      <a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dfHO8ItrV_BTL_0P7o4SJRdSf3s7PA64b2wUbD5tRnVt1xr0t0ZUqIgoujj7RAh3ugsc8UmN2rdBG1wqf3LiEYN0aaleJ5OnVkwghF7m-SL&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
          Join LinkedIn and access Guvenc Kockaya, MD, MSc&#8217;s full profile. It's free!
      </a>
    </h2>
  </div>
  <div class="content">
    <p>As a LinkedIn member, you'll join 225 million other professionals who are sharing connections, ideas, and opportunities.</p>
    
      <ul>
        <li>See who you and <strong>Guvenc Kockaya, MD, MSc</strong> know in common</li>
        <li>Get introduced to <strong>Guvenc Kockaya, MD, MSc</strong></li>
        <li>Contact <strong>Guvenc Kockaya, MD, MSc</strong> directly</li>
      </ul>
    
  </div>

  

  
    <p id="show-expanded" class="actions ">
      
        <a class="btn-action" id="regform-show" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dfHO8ItrV_BTL_0P7o4SJRdSf3s7PA64b2wUbD5tRnVt1xr0t0ZUqIgoujj7RAh3ugsc8UmN2rdBG1wqf3LiEYN0aaleJ5OnVkwghF7m-SL&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
          View Guvenc's full profile
        </a>
        
      
    </p>
  

  

  
</div>













              

            

          </div>

          

          

          
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      


















<h2 class="section-title">Guvenc Kockaya, MD, MSc's Overview </h2>
<dl id="overview">
  
  
  <dt id="overview-summary-current-title" class="summary-current" style="display:block">
    Current
  </dt>
  <dd class="summary-current" style="display:block">
    
        <ul class="current">
			    
			      <li>
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Healthcare Economics, Policy &amp; Reimbursement Manager, Turkey &amp; Azerbaijan
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/covidien_2?trk=ppro_cprof"><span class="org summary">Covidien</span></a>
        
    
	








			        
			      </li>
			    
			      <li>
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Engaged in various groups
      
    
    
      <span class="at">at </span>
      Health Economics &amp; Policy Association
    
	








			        
			      </li>
			    
        </ul>
		    
		    
			  
      
  </dd>
  

  
  
  <dt id="overview-summary-past-title" class="summary-past" style="display:block">  
    Past
  </dt>
  <dd class="summary-past" style="display:block">
    
        <ul class="past">
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Member of Sub-Commission of Pharmaceutical Expenditure Monitoring and Evaluation
      
    
    
      <span class="at">at </span>
      Social security Institution(SGK)
    
	








		      </li>
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Medical and Economic Evaluation Commission for Pharmaceuticals Associate Member
      
    
    
      <span class="at">at </span>
      Social Security Institution (SGK)
    
	








		      </li>
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Health Economist
      
    
    
      <span class="at">at </span>
      Turkey Pharmaceutical and Medical Device Agency
    
	








		      </li>
		    
		    </ul>
		    
        
        
          <div class="showhide-block" id="morepast">
            <ul class="past">
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Part-time Lecturer
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/yeditepe-university?trk=ppro_cprof"><span class="org summary">Yeditepe University</span></a>
        
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Columnist
      
    
    
      <span class="at">at </span>
      StratejiEvi.com
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Medical Advisor
      
    
    
      <span class="at">at </span>
      Medvice Medical Consultancy
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Ambulance Physician
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/saglik-bakanligi?trk=ppro_cprof"><span class="org summary">Ministry of Health</span></a>
        
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    District Rotaract Representative
      
    
    
      <span class="at">at </span>
      Rotaract District 2420
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Medical Manager
      
    
    
      <span class="at">at </span>
      Farma-tek Pharmaceuticals
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Provision Officer
      
    
    
      <span class="at">at </span>
      MDS Health
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Sales Head
      
    
    
      <span class="at">at </span>
      Esen Medikal
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Anchor Person
      
    
    
      <span class="at">at </span>
      SRT (Sivas Radio&amp;Television)
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    DJ
      
    
    
      <span class="at">at </span>
      Arkadas FM
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Author
      
    
    
      <span class="at">at </span>
      Yeni Ulke
    
	








                </li>
              
            </ul>
            <p class="seeall showhide-link"><a href="#" id="morepast-hide">see less</a></p>
          </div>
          <p class="seeall showhide-link"><a href="#" id="morepast-show">see all</a></p>
      
      
  </dd>
  

  
  
    <dt id="overview-summary-education-title" class="summary-education" style="display:block"> 
       Education
    </dt>
    <dd class="summary-education" style="display:block">
      
		      <ul>
		        
              
 		          <li>
	              Istanbul University
		          </li>
		          
		        
              
 		          <li>
	              Universit&#xe9; Claude Bernard (Lyon I)
		          </li>
		          
		        
              
 		          <li>
	              Temple University
		          </li>
		          
		        
		      </ul>
		      
		      
		        <div class="showhide-block" id="moreedu">
		          <ul>
		            
                
		            <li>
		              <div name="education">
		              
		                Yeditepe &#xdc;niversitesi
		              
		              </div>
		            </li>
		            
		            
                
		            <li>
		              <div name="education">
		              
		                Istanbul University
		              
		              </div>
		            </li>
		            
		            
                
		            <li>
		              <div name="education">
		              
		                Mimar Sinan G&#xfc;zel Sanatlar &#xdc;niversitesi
		              
		              </div>
		            </li>
		            
		            
                
		            <li>
		              <div name="education">
		              
		                Sel&#xe7;uk Anadolu Lisesi
		              
		              </div>
		            </li>
		            
		            
		          </ul>
                <p class="seeall showhide-link"><a href="#" id="moreedu-hide">see less</a></p>
		        </div>
                <p class="seeall showhide-link"><a href="#" id="moreedu-show">see all</a></p>
		      
        
    </dd>
  
  
  
  
    <dt>
       Recommendations
    </dt>
    <dd>
      <p>
        
            
                <strong>1</strong> person has recommended Guvenc
              
          
      </p>
    </dd>
  

  
  
    
    <dt>
      Connections
    </dt>
    <dd class="overview-connections">
      <p>
      
        <strong>500+</strong>  connections
      
      </p>
    </dd>
    
  

  
  
  
  
  
    

  
  
  
  
  
    
  
</dl>

<script type="text/javascript">
  showHide.init('overview');
</script>











          

          
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      












  <div class="section" id="profile-summary" style="display:block">

    <div class="header">
      <h2>
				Guvenc Kockaya, MD, MSc's Summary
				
				
			</h2>
    </div>

    <div class="content">

      
      
      
        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description summary">
    Performs Pharmacoeconomic Analysis and Health Outcome Analysis for Covidien Turkey &amp; Azerbaijan. Worked as Health Economist for Ministry of Health. Studied in Pharmacoeconomy and Pharmacoepidemiology Master Program and Studying in Pharmacology and Clinical Pharmacology PhD Program.
</p>


    
      
      
	      
	      
	        <div id="profile-specialties" style="display:block">
	        <h4>Specialties</h4>
            
              <p class="null">Health Outcome, Pharmacoeconomy, Pharmaocepidemiology, Pharmaceutical Marketing, Medical Devices, Emergency Medicine</p>
            
	        </div>
	      
    </div>
  </div>









	            
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      








<div class="section subsection-reorder" id="profile-experience" style="display:block">
  <div class="header">
    <h2>Guvenc Kockaya, MD, MSc's Experience
	  </h2>
  </div>
  <div class="content vcalendar">
  <div> 
    <div>
    <div class="position  first experience vevent vcard summary-current" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Healthcare Economics, Policy &amp; Reimbursement Manager, Turkey &amp; Azerbaijan</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/covidien_2?trk=ppro_cprof"><span class="org summary">Covidien</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details current-position">
  	        Public Company; 10,001+ employees; COV;
	  	      Medical Devices industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2012-02-01">February 2012</abbr>
  	              &#8211; <abbr class="dtstamp" title="2013-09-20">Present</abbr>
  	          <span class="duration"><span class="value-title" title="P1Y8M"> </span>(1 year 8 months)</span>
                  
       
     
                      <span class="location">Ankara, Turkey</span>
                  
       
     
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description current-position">
    To provide leadership to support development and implementation of strategic plans at the territorial level that optimize the economic value of the portfolio for Turkey and Azerbaijan area. Support closer regions (Middle East &amp; Eastern Europea) for optimization of the economic value of the portfolio.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-current" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Engaged in various groups</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Health Economics &amp; Policy Association</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details current-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2011-09-01">September 2011</abbr>
  	              &#8211; <abbr class="dtstamp" title="2013-09-20">Present</abbr>
  	          <span class="duration"><span class="value-title" title="P2Y1M"> </span>(2 years 1 month)</span>
  	    </p>
        
       
     

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Member of Sub-Commission of Pharmaceutical Expenditure Monitoring and Evaluation</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Social security Institution(SGK)</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2011-06-01">June 2011</abbr>
 &#8211; <abbr class="dtend" title="2012-01-01">January 2012</abbr>  	          <span class="duration"><span class="value-title" title="P8M"> </span>(8 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    To monitor and evaluate the expenditure of pharmaceuticals in Turkey.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Medical and Economic Evaluation Commission for Pharmaceuticals Associate Member</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Social Security Institution (SGK)</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2010-09-01">September 2010</abbr>
 &#8211; <abbr class="dtend" title="2012-01-01">January 2012</abbr>  	          <span class="duration"><span class="value-title" title="P1Y5M"> </span>(1 year 5 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Evaluate the Reimbursement Dossiers and Declarate Reimbursement Decisions for Pharmaceuticals.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Health Economist</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Turkey Pharmaceutical and Medical Device Agency</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2010-05-01">May 2010</abbr>
 &#8211; <abbr class="dtend" title="2012-01-01">January 2012</abbr>  	          <span class="duration"><span class="value-title" title="P1Y9M"> </span>(1 year 9 months)</span>
                  
       
     
                      <span class="location">Ankara, Turkey</span>
                  
       
     
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Write desicion reports for the reimbursement,new forms, new indication aplications or any question of the pharmaceutical firms to the SGK or any foundation.Attend to the reimbursement comitees and regulatory committees for pharmaceuticals.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Part-time Lecturer</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/yeditepe-university?trk=ppro_cprof"><span class="org summary">Yeditepe University</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Educational Institution; 1001-5000 employees;
	  	      Higher Education industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2010-10-01">October 2010</abbr>
 &#8211; <abbr class="dtend" title="2011-05-01">May 2011</abbr>  	          <span class="duration"><span class="value-title" title="P8M"> </span>(8 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Pricing and reimbursement process in Turkey, regulations, contents of application dossiers, preparing of application dossiers and approaches of the goverment`s side. Pharmacoeconomic analysis for Turkey, adapting analysis of foreign countries to Turkey. Study on examples of cost-minimization, cost-effectiveness and QALY analysis. Perform analysis from begining (data mining) to the end with examples.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Columnist</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">StratejiEvi.com</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2010-04-01">April 2010</abbr>
 &#8211; <abbr class="dtend" title="2010-06-01">June 2010</abbr>  	          <span class="duration"><span class="value-title" title="P3M"> </span>(3 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Writing Technical Analysis of Financial Instruments, Especially Forex and VOB 30.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Medical Advisor</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Medvice Medical Consultancy</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2009-02-01">February 2009</abbr>
 &#8211; <abbr class="dtend" title="2010-05-01">May 2010</abbr>  	          <span class="duration"><span class="value-title" title="P1Y4M"> </span>(1 year 4 months)</span>
  	    </p>
        
       
     

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Ambulance Physician</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/saglik-bakanligi?trk=ppro_cprof"><span class="org summary">Ministry of Health</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Government Agency; 1001-5000 employees;
	  	      Hospital & Health Care industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2007-12-01">December 2007</abbr>
 &#8211; <abbr class="dtend" title="2010-05-01">May 2010</abbr>  	          <span class="duration"><span class="value-title" title="P2Y6M"> </span>(2 years 6 months)</span>
  	    </p>
        
       
     

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">District Rotaract Representative</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Rotaract District 2420</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2008-07-01">July 2008</abbr>
 &#8211; <abbr class="dtend" title="2009-06-01">June 2009</abbr>  	          <span class="duration"><span class="value-title" title="P1Y"> </span>(1 year)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Each district is encouraged to develop a district Rotaract organization, headed by the district<br>
Rotaract representative, to carry out the following responsibilities:<br>
1. Develop and distribute a district Rotaract newsletter.<br>
2. Plan, arrange, and hold a district Rotaract conference.<br>
3. Encourage attendance and participation at the Rotary district conference.<br>
4. Conduct Rotaract promotion and extension activities throughout the district in coordination with the district Rotaract chair.<br>
5. Serve as the district&#x2019;s Rotaract information liaison to the RI Secretariat.<br>
6. Plan and implement service activities (if approved by three-fourths of the Rotaract clubs in the district).<br>
7. Provide advice and support to Rotaract clubs in implementing their projects. <br>
8. Work with the district Rotaract chair to help coordinate Rotary and Rotaract activities in the district.<br>
9. Coordinate public relations activities for Rotaract at the district level <br>
10. Work with the district Rotaract chair to plan and implement a training session for Rotaract club officers in the district.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Medical Manager</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Farma-tek Pharmaceuticals</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2008-06-01">June 2008</abbr>
 &#8211; <abbr class="dtend" title="2009-02-01">February 2009</abbr>  	          <span class="duration"><span class="value-title" title="P9M"> </span>(9 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Medical Manager and Bussiness Development
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Provision Officer</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">MDS Health</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2006-05-01">May 2006</abbr>
 &#8211; <abbr class="dtend" title="2007-11-01">November 2007</abbr>  	          <span class="duration"><span class="value-title" title="P1Y7M"> </span>(1 year 7 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Work for Yapi Kredi Insurance Company as a medical advisor for our costumers and to give provision for reimbursement of our costumers` medical procedures in any hospital.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Sales Head</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Esen Medikal</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="1998-06-01">June 1998</abbr>
 &#8211; <abbr class="dtend" title="2004-09-01">September 2004</abbr>  	          <span class="duration"><span class="value-title" title="P6Y4M"> </span>(6 years 4 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Bid on Goverment Auctions for selling Medical Products
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Anchor Person</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">SRT (Sivas Radio&amp;Television)</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2001-03-01">March 2001</abbr>
 &#8211; <abbr class="dtend" title="2001-07-01">July 2001</abbr>  	          <span class="duration"><span class="value-title" title="P5M"> </span>(5 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Produce&amp;Present the TV Show that called &quot;Kim Kimdir?&quot; in which had interviews with people who are famous in Sivas
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">DJ</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Arkadas FM</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="1997-08-01">August 1997</abbr>
 &#8211; <abbr class="dtend" title="2001-03-01">March 2001</abbr>  	          <span class="duration"><span class="value-title" title="P3Y8M"> </span>(3 years 8 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Produce&amp;Present Hard Rock&amp;Heavy Metal Radio Show
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Author</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Yeni Ulke</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="1998-07-01">July 1998</abbr>
 &#8211; <abbr class="dtend" title="1999-03-01">March 1999</abbr>  	          <span class="duration"><span class="value-title" title="P9M"> </span>(9 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Columnist in Yeni Ulke that published in Sivas
</p>

  

  	  </div>
			</div>
  </div>
   
  </div>
</div>



              
          
            
              
              
              
              
              
              
              
              
              
               
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      














  

  <div class="section" id="profile-honorsawards" style="display:block">
    <div class="header">
      <h2> Guvenc Kockaya, MD, MSc's Honors and Awards
        
      </h2>
    </div>

    <div class="content">
      
      
      
        
        <ul class="honorawards documents">
          
            <li class="honoraward  first">
  
              
              <h3>
                High Honor Graduate
                
              </h3>
              
       
     
                
                
                  <div class="org-position">Yeditepe University</div>
                                
                

                
                
                  <ul class="specifics">
                  
                    
                      <li>2010</li>  
                    
                  
                    
                    
                      
                    
                  
                  </ul>
                
                
              
       
     

              


              
            </li>
          
            <li class="honoraward ">
  
              
              <h3>
                ISPOR Meeting Travel Scholarship Award 2011
                
              </h3>
              
       
     
                
                
                  <div class="org-position">ISPOR</div>
                                
                

                
                
                  <ul class="specifics">
                  
                    
                      <li>2011</li>  
                    
                  
                    
                    
                      
                    
                  
                  </ul>
                
                
              
       
     

              


              
            </li>
          
        </ul>
      
    </div>

  </div>











              
              
              
              
          
            
              
              
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      























  <div class="section" id="profile-skills" style="display:block">

    <div class="header">
      <h2>Guvenc Kockaya, MD, MSc's Skills &amp; Expertise
        
        
      </h2>
    </div>

    <div class="content">
      
      
      

        
            
            
            <ol class="skills" id="skills-list">
                        
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Health+Economics?proficiency=">
                        
                          Health Economics
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmacoeconomics?proficiency=">
                        
                          Pharmacoeconomics
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmaceuticals?proficiency=">
                        
                          Pharmaceuticals
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Clinical+Research?proficiency=">
                        
                          Clinical Research
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Government+Affairs?proficiency=">
                        
                          Government Affairs
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmaceutical+Industry?proficiency=">
                        
                          Pharmaceutical Industry
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Reimbursement?proficiency=">
                        
                          Reimbursement
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Healthcare+Reimbursement?proficiency=">
                        
                          Healthcare Reimbursement
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Cost+Effective?proficiency=">
                        
                          Cost Effective
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Health+Policy?proficiency=">
                        
                          Health Policy
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medical+Devices?proficiency=">
                        
                          Medical Devices
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Outcomes+Research?proficiency=">
                        
                          Outcomes Research
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Oncology?proficiency=">
                        
                          Oncology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medical+Education?proficiency=">
                        
                          Medical Education
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biotechnology?proficiency=">
                        
                          Biotechnology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Government?proficiency=">
                        
                          Government
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Hospitals?proficiency=">
                        
                          Hospitals
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/HTA?proficiency=">
                        
                          HTA
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medicine?proficiency=">
                        
                          Medicine
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Healthcare?proficiency=">
                        
                          Healthcare
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Evidence-based+Medicine?proficiency=">
                        
                          Evidence-based Medicine
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Regulatory+Affairs?proficiency=">
                        
                          Regulatory Affairs
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Sales+Effectiveness?proficiency=">
                        
                          Sales Effectiveness
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Market+Access?proficiency=">
                        
                          Market Access
                        
                      </span>
                    
                  </li>
                
                
       
     
              
            </ol>
          
       
        
          
            
              <p class="see-more-less">
                <a href="#">
                  <span class="more-text">View All (24) Skills</span>
                  <span class="less-text">View Fewer Skills</span>
                </a>
              </p>
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    



   



  
  



  




  
    
  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736662-1" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _toggleclass */
          
        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-8736662-1', 'ToggleClass', { classname: 'view-all-skills', on: '#profile-skills' });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
          
        
        
      
    </div>

  </div>














              
              
              
              
              
              
              
              
              
          
            
              
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      

      
        
      











  


  

  <div class="section" id="profile-certifications" style="display:block">
    <div class="header">
      <h2>Guvenc Kockaya, MD, MSc's Certifications
        
      </h2>
    </div>
    
    
    <div class="content">
      
      
      
        
        <ul class="certifications documents">
          
            <li class="certification first">
              <h3>
                Application and Registration Process of Allergen Products
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">European Commission - TAEIX</li><li><span class="dtstart">2010</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Health Technology Assessment
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">NICE</li><li><span class="dtstart">2010</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Introduction to Pharmacoeconomics
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">ISPOR</li><li><span class="dtstart">2010</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Introduction to Clinical and Translational Research
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">Temple University</li><li><span class="dtstart">2010</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Certificate of Emergency Physician
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">Ministry of Health</li><li><span class="dtstart">2008</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Certificate of 3 Star CMAS Diver
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">CMAS</li><li><span class="dtstart">2007</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Certificate of Family Practitioner
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">Ministry of Health of Turkey</li><li><span class="dtstart">June 2011</span> to <span class="dtend">December 2017</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Certificate of Yacht&amp;Boat
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">Federation of Amateur Yacthing</li><li><span class="dtstart">July 2011</span> to <span class="dtend">July 2016</span></li>
                </ul>
                
              
       
     
            </li>
          
            <li class="certification">
              <h3>
                Product Safety Specialist
                
              </h3>
              
              
              
       
     
              
                <ul class="specifics"><li class="fn org">Ministry of Health</li><li><span class="dtstart">November 2011</span></li>
                </ul>
                
              
       
     
            </li>
          
        </ul>
      
    </div>
  
  </div>
  

  








              
              
              
              
              
              
              
              
              
              
          
            
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      

      
        
      
















  

  <div class="section" id="profile-publications" style="display:block">

    <div class="header">
      <h2>Guvenc Kockaya, MD, MSc's Publications
        
    </h2>
  </div>

    <div class="content">
      
      
      
        
        <ul class="publications documents">
          
            <li class="publication vevent vcard first">
              <h3>
                
                    <cite>Will Translational Science Help Reduce Costs of Illness?</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>INNOVATIONS in Pharmacy</li><li class="dtstart">2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    The purpose of this commentary is to (1) review the definition and potential benefits of translational science research, (2) comment on funding trends for translational science, (3) pose a question for scientists to discuss, and (4) propose recommendations for such a discussion.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736664-2" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _showmore */
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    
LI.i18n.register( 'ShowMore-see-more', 'more' );
LI.i18n.register( 'ShowMore-see-less',   'less' );
LI.i18n.register( 'ShowMore-see-more-long',   'Show more' );
LI.i18n.register( 'ShowMore-see-less-long',   'Show less' );

        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-8736664-2', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Will A Fixed Price Reimbursement Policy Work for Turkey`s Health System? What is the Cost-Effective Statin for Turkey?</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>INNOVATIONS in Pharmacy</li><li class="dtstart">2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    The Turkish Statistics Instution declared that The Social Security Foundation (SGK), which covers nearly 70% of all health expenses in Turkey, is the biggest reimbursement foundation in Turkey in its report of 22.2.2010 ( www.tuik.gov.tr). SGK wanted to begin a fixed price reimbursement policy for statins and some other medicines in December 2009 in the hope of reducing budget expenses.  However, Pharmacists Associations and pharmaceutical companies protested the approach because of proposed decreases in reimbursement. SGK delayed the fixed price reimbursement policy due to such large protests and declared on their web site that the fixed price reimbursement policy would be started, not only for statins, but also for angiotensin receptor blockers, angiotensin converting enzyme blockers, beta-blockers, proton pump inhibitors, etc. in the near future. SGK needed to decide the precise fixed reimbursement price for all using pharmacoeconomic approaches.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736664-3" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736664-3', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>What are the top most costly diseases for USA? The alignment of burden of illness with prevention and screening expenditures.</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal Health</li><li class="dtstart">2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Background:<br>
It was the intention of the authors to generate a list of the top diseases responsible for the greatest financial expense in the United States.  This listing would then inform policymakers as to the highest priority target conditions. With such information available, funding for the NIH could be accomplished based upon factual criteria rather than political clout or uninformed consensus.<br>
<br>
Method:<br>
The first step was a literature review to explore articles and reports which were published about the cost of illness (COI) up to December 2009.  Therefore the source of the data used in this investigation was obtained from this retrospective search approach.  <br>
<br>
Results:<br>
With reference to total cost for disease, first was HCVD with 475.3 billion US dollars, followed by alcohol abuse and substance at 300.6 billion US dollars, digestive diseases at 259.6 billion US dollars, cancer at 239.5 billion US dollars and mental disease at 216,6 billion US dollars.<br>
<br>
Conclusion:<br>
As has been seen, the total societal costs of the diseases do not synch with the degree of attention paid to these various disease states.  Several of the diseases have very powerful and vocal support organizations that encourage attention and clinical research support.  On the other hand we hear very little about efforts against allergic rhinitis or infectious and parasitic diseases.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736665-4" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736665-4', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Compare Angiotensin receptor blockers in hypertension treatment depending on Year 2010 data from reimburstment foundatIon view</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>MN Cardiology</li><li class="dtstart">2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Objective: Hypertension was the one of important risk factors in preventable cardiovascular risk factors. The   aim of this study is determine the cost effective anjiotensin reseptor blokers and combinations which have great percentage in Turkey antihypertension market.<br>
<br>
Methods: Efectiveness of anjiotensin receptor blokers and combinations were taken from a published meta-analysis. Costs were calculated depending on designed treatment protocol and icrementel cost effectiveness analysis was done.<br>
<br>
Results: Depending on designed treatment protocol losartan and combination were present the least costly treatment and 52 week treatment cost per patient was 423 TL. Losartan was comparable with irbesartan in incremental cost effectiveness analysis. Candesartan was dominated by losartan and valsartan was dominated by irbesartan.<br>
<br>
Conclusion: Losartan strategy was present the least costly treatment and irbesatan strategy was present the most responders patients to treatment. Reimbursment foundation may be give priority to these two anjiotensin receptor blockers in hypertension treatment.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736665-5" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736665-5', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Considering the cost-effectiveness of statins in Family Practice in Turkey from a payer perspective</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal Health</li><li class="dtstart">2009</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>, P&#x131;nar Daylan Ko&#xe7;kaya, Ahmet Esen
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    The percentage of mortality caused by cardio-vascular events in European Countries and Euro-pean Union Countries is respectively 49% and 42% of all mortality causes. Our estimates about cardiovascular mortality in Turkey depend on TEKHARF (Hearth Disease and Risk Factors in Turkish Adults ) which depended on a 12 year observation. It has been reported that cardio-vascular mortality rates for Turkey in men and women were 0.082% and 0.043% respectively. In Turkey, Atorvastatin, Fluvastatin, Pravastatin, Rosuvastatin and Simvastatin are the different alternatives found in the statin market. All stat-ins are reimbursed by insurance companies. The aim of this study is to determine the cost- effective of statins. In conclusion, simvastatin and rosuvastatin comprised the optimal two statin alternatives.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736665-6" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736665-6', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fjpp%2Esagepub%2Ecom%2Fcontent%2Fearly%2F2010%2F12%2F10%2F0897190010389336%2Eabstract&amp;urlhash=dkE1" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Can We Reduce the Cost of Illness With More Compliant Patients? An Estimation of the Effect of 100% Compliance to Treatment of Hypertension</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Pharmacy Practice</li><li class="dtstart">December 20, 2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Introduction: The current study was designed to calculate the direct cost of noncompliance of hypertensive patients to the US health system. Understanding these expenses can inform screening and education budget policy regarding expenditure levels that can be calculated to be cost-beneficial. Method: The study was conducted in 3 parts. First, a computer search of National Institutes of Health Web sites and professional society Web sites for organizations with members that treat hypertension, and a PubMed search were performed to obtain the numbers required for calculations. Second, formulas were developed to estimate the risk of noncompliance and undiagnosed hypertension. Third, risk calculations were performed using the information obtained in part 1 and the formulas developed in part 2. Results: Direct risk reduction for stroke caused by hypertension, heart attack, kidney disease, and heart disease was calculated for a 100% compliant strategy. Risk, case, and cost reduction for a 100% compliant strategy for hypertension were 32%, 8.5 million and US$ 72 billion, respectively. Discussion: Our analysis means that the society can spend up to the cost of noncompliance in screening, education, and prevention efforts in an attempt to reduce these costly and traumatic sequelae of poorly controlled hypertension in the light of published analysis.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736666-7" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736666-7', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fonlinelibrary%2Ewiley%2Ecom%2Fdoi%2F10%2E1111%2Fj%2E1759-8893%2E2011%2E00041%2Ex%2Fabstract&amp;urlhash=bRcV" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Off-label and unlicensed oncology medicine use in Turkey: a retrospective analysis of computer records of the Turkish Ministry of Health</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Pharmaceutical Health Services Research</li><li class="dtstart">March 14, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, Mine Polat, &#xc4;&#xb0;smail Mert Vural, Akif Akbulat, Bur&#xc3;&#xa7;ak Deniz Dedeo&#xc4;&#x9f;lu, Halil Akar, Saim Kerman
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Objectives&#xe2;&#x80;&#x82; The use of off-label medications is very common. A study published in 2006 found that off-label use was most common for cardiac medications and anticonvulsants. The study also found that 73% of off-label use had little or no scientific support. Off-label use can lead to restrictions regarding reimbursement. Regulatory agencies have created incentives to extend indications for approved drugs in order to remove them from the off-label area. In our analysis, off-label or unlicensed use of oncology medicines was evaluated so as to provide an understanding of Turkey's perspective within this area of medical provision.<br>
<br>
Methods&#xe2;&#x80;&#x82; Unlicensed or off-label medicine use in Turkey is controlled by the General Directorate of Pharmaceuticals and Pharmacy (GDPP) of the Turkish Ministry of Health. Oncology medicines are imported for these types of uses. A computer search was performed of GDPP's database. A patient base using off-label oncology medicines applications in the years 2008, 2009 and first 6 months of 2010 was searched.<br>
<br>
Key findings&#xe2;&#x80;&#x82; Our study showed that the use of unlicensed or off-label medicine has been rising in recent years and there was a huge difference between incidence and applications in haematologic and breast cancers.<br>
<br>
Conclusions&#xe2;&#x80;&#x82; It can be said that awareness of off-label medicine use is increasing in Turkey, with physicians able to reach scientific literature immediately via the Internet. It might also be said that physicians and pharmaceutical firms may try to avoid the reimbursement procedures of the Turkish Social Security Institution by using GDPP off-label use procedures. It is necessary to evaluate off-label and unlicensed use procedures a bit more strictly. Further analysis will be required in the future.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736666-8" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736666-8', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eiegm%2Egov%2Etr%2FDefault%2Easpx%3Fsayfa%3Dduyuru%26lang%3Dtr-TR%26newsId%3D489&amp;urlhash=0G9E" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>ILAC VE ECZACILIK GENEL MUDURLUGU  CALISANLARININ  EQ-5D FORMU ILE YASAM KALITESI DEGRLENDIRME CALISMASI</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>IEGM</li><li class="dtstart">January 31, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, Akif Akbulat, Murat Baran, Fikri Yildirim, I.Mert Vural, Halil Akar, Saim Kerman
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736667-9" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736667-9', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eiegm%2Egov%2Etr%2FDefault%2Easpx%3Fsayfa%3Danasayfa%26lang%3Dtr-TR%26newsId%3D550&amp;urlhash=PUxj" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Report of Workshops of Evaluation Structure of Health Technology Assessment Agencies</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>IEGM</li><li class="dtstart">April 25, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, Saim Kerman, Mahmut Toka&#xc3;&#xa7;, Halil Akar, Akif Akbulat, &#xc4;&#xb0;smail Mert Vural
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    It is apparent that evaluation and implanting the results of the workshops which will be example and resource for the further seminars and meetings can provide great contribution for economy of country and cause improving for the health expenditures. Improving the physical structure and educated personel for initating the assessment process is necessary and going to take place in time.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736667-10" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736667-10', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Epharmacy%2Eumn%2Eedu%2Finnovations%2Fprod%2Fgroups%2Fcop%2F%40pub%2F%40cop%2F%40innov%2Fdocuments%2Farticle%2Fcop_article_344357%2Epdf&amp;urlhash=za_L" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>An estimation of the effect of 100% Compliance with Diabetes Treatment: Can we reduce  cost of illness with higher compliance rates?</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>INNOVATIONS in Pharmacy</li><li class="dtstart">June 28, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Introduction: The current study was designed to estimate the direct cost of noncompliance of diabetes patients to the US health <br>
system. Understanding these expenses can inform screening and education budget policy regarding expenditure levels that can be <br>
calculated to be cost-beneficial.<br>
Materials and Method: The study was conducted in three parts. First, a computer search of National Institutes of Health websites <br>
and professional society websites for organizations with members that treat diabetes, and a PubMed search were performed to <br>
obtain the numbers required for calculations. Second, formulas were developed to estimate the risk of non-compliance and <br>
undiagnosed diabetes. Third, risk calculations were performed using the information obtained in part one and the formulas <br>
developed in part two.<br>
Results: Direct risk reduction for diabetes-related kidney disease, stroke, heart disease, and amputation were estimated for 100% <br>
compliance with diabetes treatment.  Risk, case and yearly cost reduction calculated for a 100% compliance with diabetes treatment<br>
were 13.6%, 0.9 million and US$ 9.3 billion, respectively. <br>
Conclusion: Society, insurers, policy makers and other stakeholders could invest up to these amounts in screening, education and <br>
prevention efforts in an effort to reduce these costly and traumatic sequelae of noncompliant diabetes patients.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736667-11" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736667-11', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Ejapsonline%2Ecom%2Fvol-1_issue-5%2F13%2Epdf&amp;urlhash=zT3C" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Cost effectiveness analysis of five different treatment  alternatives in seasonal allergic conjunctivitis</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Applied Pharmaceutical Sciences</li><li class="dtstart">July 27, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    ABSTRACT<br>
Seasonal allergic conjunctivitis is an illness which decreases quality of life and is common in society. Pharmacoeconomic evaluation about seasonal alergic conjunctivitis has not <br>
been measured in Turkey. The aim of our study is to understand the cost-effective medicines which are used for seasonal allergic conjunctivitis with Turkish data. In our study, effectiveness <br>
data from randomized controlled trials done with fluorometholon, epinastin, olopatadin, emedastin and ketotifen were used. Different effectiveness data reported in the trials were reduced to one single dataset. For cost data, direct costs like drug cost and physician meetings were counted in the calculation. Incremental cost effectiveness analysis (ICER) was performed with effectiveness and cost data which were obtained. In cost analysis lowest treatment cost was established by fluorometholon (US$ 38.94) and followed by ketotifen (US$ 43.41),epinastine (US$ 43.60), olopatadine (US$ 44.05) and emedastine (US$ 44.92), respectively. When the drugs compared for incremental cost-effectiveness, emedastine was dominated by ketotifen and <br>
emedastine dominated by olopatadine; ketofien could be compared with fluorometholon and olopatadine. Turkish data obtained and analyzed were similar with the literature. Reimburstment foundations can feature preparations which contain olopatadin and epinastin in treatment protocols, in the light of obtained data.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736668-12" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736668-12', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Ebenthamscience%2Ecom%2Fopen%2Ftopharmej%2Farticles%2FV003%2F1TOPHARMEJ%2Epdf&amp;urlhash=Dk8P" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>The Cost of Neuromuscular Blockers in Operations of Variable Length in  Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>The Open Pharmacoeconomics &amp; Health Economics Journal</li><li class="dtstart">August 17, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, P&#x131;nar Daylan Ko&#xe7;kaya, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Decision makers develop new strategies to minimize the anesthetic costs and maintain the quailty of health <br>
care. The aim of our study is to help decision makers, in Turkey, in developing new strategies to minimize anesthetic <br>
costs. Three different operational strategies were assumed. The first strategy was for operations under 30 minutes; the <br>
second strategy was for operations between 30 and 60 minutes and the third strategy was for operations above 60 minutes. <br>
Neuromusculer blocker cost by milligram per kilogram was calculated for each operation strategy. Atracurium had the <br>
lowest per milligram cost (US$0.08), followed by rocuronium (US$0.09), mivacurium (US$0.38), vecuronium (US$0.44) <br>
and cisatracurium (US$0.59). Atracurium and vecuronium had the lowest costs in operations which are under 30 minutes, <br>
followed by rocuronium, mivacurium and cisatracurium. Vecuronium had the lowest costs in operations which are 30-60 <br>
minutes, followed by atracurium, rocuronium and cisatracurium. Vecuronium which had the lowest costs in operations <br>
above 60 minutes, followed by atracurium, rocuronium and cisatracurium. The managements of hospitals or hospital <br>
groups which are in Turkey can choose atracurium and vecuronium in operations under 30 minutes, vecuronium in <br>
operations 30-60 minutes and above 60 minutes in their neuromuscular blocker (NMB) formularies for making cost <br>
reductions from NMBs.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736668-13" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736668-13', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Farmakoekonomi Derken?</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Turkey Pharmaceutical Representative</li><li class="dtstart">April 1, 2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Farmakoekonomik Ara&#x15f;t&#x131;rma Teknikleri Mi Varm&#x131;&#x15f;?</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Turkey Pharmaceutical Representative</li><li class="dtstart">May 1, 2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Farmakoekonomi Y&#xfc;kselirken</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Turkey Pharmaceutical Representative</li><li class="dtstart">June 1, 2010</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>ANALYSIS OF RESULTS OF THE REFERENCE PRICING OF TURKEY</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 14th European Congress</li><li class="dtstart">October 7, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>ORPHAN MEDICINE EXPENDITURES IN TURKEY</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>6th Eastern European Conference for Rare Diseases and Orphan Drugs</li><li class="dtstart">November 11, 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eanakarder%2Ecom%2Fyazilar%2Easp%3Fyaziid%3D2344%26sayiid%3D32&amp;urlhash=zxY5" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Performed pharmacoeconomic assessments on anti-hypertension and anti-lipidemia medicines for Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>The Anatolian Journal of Cardiology</li><li class="dtstart">February 7, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>REFERENCE PRICINIG PROPOSAL BASED ON GROSS DOMESTIC PRODUCT PER CAPITA</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 17th Annual International Meeting</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526">Albert Wertheimer</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eyeditepemj%2Ecom%2Fyjm%2FManuscripts%2FMarch-2012%2F-p-Kockaya-G%2CTanyeri-P-%2CVural-M-%2CAkbulat-A%2CAkar-H%2C%2Easpx&amp;urlhash=D2l3" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>OFF-LABEL AND  UNLICENSED  ENDOCRINOLOGY  MEDICINE USE IN TURKEY:  A RETROSPECTIVE  ANALYSIS OF COMPUTER  RECORDS IN THE TURKISH  MINISTRY OF HEALTH</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Yeditepe Medical Journal</li><li class="dtstart">March 21, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    &#x201c;Off-label&#x201d; is defined by the <br>
Turkish Ministry of Health as the use of <br>
licensed pharmaceutical products in doses <br>
outside the scope of the registered <br>
indication and the use of  unlicensed <br>
medicinal products  that are imported  for <br>
the purpose of individual treatment. Aim <br>
of the study is to evaluate the use of offlabel or unlicensed endocrinology <br>
medicines
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736670-14" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736670-14', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Ejapsonline%2Ecom%2Fvol-2-issue-3%2F157-159%2Epdf&amp;urlhash=tw_7" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>The Efficacy and Undesired Effects of High Dosage  Zinc Treatment</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Applied Pharmaceutical Science</li><li class="dtstart">March 1, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, <a href="http://tr.linkedin.com/pub/baran-ufuktepe/21/858/33b">Baran Ufuktepe</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Zinc is an essential micronutrient for human health. It is very important for body functions, and they have an interaction potential in several systems, including nervous system. <br>
Although there is no global regulation about the daily amounts, it is shown to reduce the <br>
incidence of diarrhea and pneumonia. Zinc deficiency is a global problem, especially in <br>
developing countries. Zinc has been shown to be effective in treatment of zinc deficiency, <br>
Acrodermatitis Enteropathica, protein energy malnutrition (PEM), Wilson disease, pica,<br>
diarrhea, unrecovering ulcers etc. Although under 50 mg daily is enough for diarrhea, anemia, <br>
infections, immundeficieny etc., higher dosages may be required in Wilson`s disease, pica and <br>
acrodermatitis enteropathica up to 220 mg daily. Also it was reported that high dosage of zinc <br>
treatment can lead neurotoxity, Alzheimer`s disease or impaired lipid metabolism. So caution <br>
should be exercised when prescribing the zinc to the patients who have risk for neurotoxity, <br>
Alzheimer`s disease or impaired lipid metabolism.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736670-15" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736670-15', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg%2Fnews%2Farticles%2FApril12%2FPharmaceutical-Policies-Market-Access-Turkey%2Easp&amp;urlhash=fHy1" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Pharmaceutical Policies and Market Access in Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR Connections</li><li class="dtstart">March 1, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, Pelin K&#x131;l&#x131;c
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    In  2002,  a  national  &#x201c;Health  Transformation  Program&#x201d;  [1],  modelled  after European  Union  (EU)  countries,  was  launched  with  the  consent  of  the Minister of Health to improve the national health care system. The re-structuring component of this program, which is still ongoing, aims to fulfill the Ministry of Health&#x2019;s (MOH) mission to assign the Directorate-General of Pharmaceuticals and Pharmacy (IEGM) as an independently operating pharmaceutical products and  medical  devices  agency  governing  all  regulatory  procedures  regarding human medicinal products, cosmetics and medical devices. IEGM is currently attached to the MOH [2]. General procedures regarding efficient and safe use of human medicinal products are practiced in a framework of legal regulations by the national competent authority, IEGM (Table 1). The preliminary aim of IEGM is to transform into a &#x201c;Pharmaceutical Products and Medical Devices Agency,&#x201d;  maintaining  timely  licensing  procedures  and  operating  programs which support computer-based transparency criteria.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736671-16" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736671-16', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Efarmakoekonomi%2Ecom&amp;urlhash=70-2" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Turkish Translation of Bootman`s &quot;Principles of Pharmacoeconomics&quot;</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Harvey Whitney Book</li><li class="dtstart">April 16, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    &quot;This is a reference without shortcomings. I recommend this highly informative, practical, well-referenced book to students and practitioners.&quot; (American Journal of Health-System Pharmacy)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736671-17" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736671-17', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fonlinelibrary%2Ewiley%2Ecom%2Fdoi%2F10%2E1111%2Fj%2E1759-8893%2E2012%2E00090%2Ex%2Fabstract&amp;urlhash=ky2b" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Compassionate medicine-use programmes in Turkey: a report on current status</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Pharmaceutical Health Services Research</li><li class="dtstart">May 25, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>, Elif Hilal Vural
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Objective&#x2002; In Turkey, compassionate use (CU) programmes were started in 2006. Patients suffering from a serious or urgent life-threatening disease, who have not responded to currently licensed and available medicinal products, who have not been enrolled in related clinical studies and who need access to products that are unlicensed in Turkey, but which are licensed/not licensed in other countries, can apply to CU programmes. These were described with the last guidelines of the Compassionate Use For Humanity Program in 2009.<br>
<br>
Methods&#x2002; We sought to find out how many programmes have been launched, which disease areas and medicines are common in the programmes and how many patients were included in CU programmes in Turkey. A computer search was performed in the General Directorate of Pharmaceuticals and Pharmacy database.<br>
<br>
Key findings&#x2002; The first programme was launched in 2006. Forty-two different CU programmes have been launched, 26 different compounds have been used in CU programmes and 1247 patients have been included in CU programmes since they began in Turkey. This means that 1247 patients, mostly with oncology-related conditions, were treated without any government funding between 2006 and 2011.<br>
<br>
Conclusion&#x2002; CU programmes are becoming more important for Turkish patients who suffer from life-threatening diseases for which no alternative authorized treatment exists. CU programmes can give options to patients, physicians and even the government for treating life-threatening diseases. Health authorities and reimbursement agencies may support the opening of new CU programmes.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736672-18" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736672-18', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>EFFECTS OF CHANGING HEALTH POLICY ON PHARMACOECONOMICS AND HEALTH OUTCOME STUDIES IN TURKEY</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 15th Annual European Meeting</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>POSSIBLE BUDGET IMPACT OF INTERNAL REFERENCE PRICING FOR STATINS IN TURKEY</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 15th Annual European Meeting</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>NET TAX REVENUE WITH A NATIONAL BASED ROTAVIRUS VACCINATION PROGRAM IN TURKEY</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 15th Annual European Meeting</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>POTENTIAL IMPACT OF REGIONAL CEREBRAL OXYGEN SATURATION MONITORING DURING CORONARY ARTERY BYPASS SURGERY ON THE PATIENT REIMBURSEMENT BUDGET IN TURKEY</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 15th Annual European Meeting,</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>ECONOMIC EFFECT OF CLINICAL TRIALS FOR TURKEY</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR 15th Annual European Meeting</li><li class="dtstart">2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <cite>Consumption Budget and Price Alteration Analyses of Angiotensin Receptor Blockers an Angiotensin Converting Enzyme Inhibitors in Turkey within Years</cite>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>MN Cardiology</li><li class="dtstart">September 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Aim: Hypertension is the most important risk factor in preventable cardiovascular risks. In this study, consumption analysis of products<br>
containing angiotensin receptor blockers (ARB) and angiotensin converting enzyme inhibitors (ACEI) was performed for assessment<br>
of the current situation.<br>
Material and Method: A computer-based analysis by using Windows Office Excel 2007 was conducted depending on the consumption<br>
data of ARB and ACEI, which were taken from Information Medical Statisticis &#x2013; Health (IMS) within years 2005-2010. Regression<br>
analysis was performed with the results of the analysis.<br>
Results: Even if the consumption of all ARB rose by 175% in boxes, the expenses of ARB in terms of TL was increased by 86% from year<br>
2005 and 2010. Even if the consumption all ADEI rose by 17, the expenses of ADEI in terms of TL was decreased 4% from year 2005<br>
to 2010, It was shown in the regression analysis that newly launched generics had a negative effect on ARB and ACEI expenses.<br>
Conclusion: The effect of hypertension to Turkey`s health budget is rising day by day due to both rising diagnoses and complications.<br>
On the other hand, it was shown that licensing and adding in to the reimbursement of new generics has an important impact on controlling<br>
health budget.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736673-19" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736673-19', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eispor%2Eorg&amp;urlhash=vNLf" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Medical Device Policies &amp; Market Access in Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>ISPOR CONNECTIONS</li><li class="dtstart">December 1, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fjournals%2Eedizioniseed%2Eit%2Findex%2Ephp%2FFE%2Findex&amp;urlhash=AbYe" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Treatment Cost of Metastatic Colon Cancer in Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Farmeconomia. Health economics and therapeutic pathways 2013; 14(1): 19-25</li><li class="dtstart">March 25, 2013</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    OBJECTIVES: Colon cancer is the third most common in the top cancer incidence list in Europe. In Europe 212,000 patients die every year due to colon cancer. In Turkey 120,000-130,000 new cancer patients are diagnosed every year, 7.1% of whom are diagnosed to have developed colon cancer. Metastases will occur in up to 50% of the patients who are newly diagnosed. Survival appears to be further prolonged to more than 20 months with new pharmaceuticals; however, these new pharmaceuticals increase the total cost of care. The aim of this study is to estimate the cost implications of new colon cancer treatment options for Turkey.<br>
METHODS: Gazi University Hospital treatment protocols for colon cancer treatment were used. Cost of FUFA (5 FU/LV), FOLFIRI, FOLFOX, bevacizumab/FUFA, bevacizumab/FOLFIRI, bevacizumab/FOLFOX, irinotecan and irinotecan/cetixumab protocols were calculated. The cost of combination of protocols were calculated depending on a Markov analysis. The exchange rate was US$ 1 for TL 1.5.<br>
RESULTS: Depending on the life expectancy the lowest total cost was established by FUVA (US$ 5,359). It was followed by FOLFIRI then FOLFOX and FOLFOX, US$ 14,144 and US$ 16,553, respectively. The lowest cost for each week of life expectancy was established by FUVA with US$ 98.<br>
CONCLUSIONS: Only FUFA, FOLFIRI followed by FOLFIX, FOLFIRI/bevacizumab then FOLFOX then cetuximab, FOLFOX/bevacizumab then irinotecan then cetuximab/irinotecan and FOLFIRI/bevacizumab then FOLFOX then cetuximab/irinotecan were under the cost effectiveness curve. In addition no treatments ICER was under the WHO`s threshold for Turkey, except FOLFIRI then FOLFOX compared with FUVA.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736674-20" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736674-20', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fjournals%2Eedizioniseed%2Eit%2Findex%2Ephp%2FFE%2Farticle%2Fview%2F473&amp;urlhash=Z06M" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Results of reference pricing and reimbursement discount rate schemes of Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Farmeconomia. Health economics and therapeutic pathways</li><li class="dtstart">June 5, 2013</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    OBJECTIVES: General Directorate of Pharmaceuticals and Pharmacy (IEGM) is responsible for setting all prices for human medicinal products. The reference pricing system is used for setting these prices. Reference countries are reviewed annually and may be subject to certain alterations. The aim of this study is to show the distribution of reference countries which were used for reference pricing.<br>
METHODS: The price list of pharmaceuticals which was published by IEGM on 15.04.2011 was used for analysis. Distribution of reference countries and prices were evaluated.<br>
RESULTS: Prices of 6,251 generic and 3,703 original products were set according to the price list. 5,283 of generics and 3,306 of originals were in the positive list for reimbursement. Reference pricing was used for 2,352 generics and 2,281 originals. Prices of the remaining were set outside of reference pricing. 32 different countries were used for reference pricing. Italy was the most popular country for reference pricing. Even if it was not a reference country, Germany was used in some of the pharmaceuticals. The average reimbursement discount rate and price were 24.43% and 249 TL, respectively. There were no colerations between price and reimbursement discount rate, or reference country and reimbursement rate.<br>
CONCLUSION: It has been shown that Italy has the highest impact on the pricing of all pharmaceuticals in Turkey. Even if it was not a reference country, Germany showed to affect pharmaceuticals more than other countries which were also not used for reference pricing. Even if reimbursement discount rates are stated by the Social Security Institution (SGK), there are different discount rates for pharmaceuticals. The analysis stated that there were correlation between price, country and discount rates. This analysis is first for the literature. Further analysis is necessary in the light of price changes and newly launched pharmaceuticals.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736674-21" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736674-21', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fonlinelibrary%2Ewiley%2Ecom%2Fdoi%2F10%2E1111%2Fjphs%2E12018%2Fabstract&amp;urlhash=1b61" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Orphan drug regulations in Turkey</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Journal of Pharmaceutical Health Services Research</li><li class="dtstart">April 24, 2013</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://tr.linkedin.com/pub/guvenc-kockaya-md-msc/18/3a4/b30">Guvenc Kockaya, MD, MSc</a>
                  
                </div>
                
              
       
     
              
              
            </li>
          
        </ul>
      
    </div>

  </div>











              
              
              
              
              
              
              
              
              
              
              
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      






  <div class="section subsection-reorder summary-education" id="profile-education" style="display:block">
    <div class="header">
      <h2>
        Guvenc Kockaya, MD, MSc's Education
      </h2>
    </div>
    <div class="content vcalendar">
			  <div> 
            <div class="position  first education vevent vcard" id="42912692">


                <h3 class="summary fn org">
                  
Istanbul University                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">PhD</span>, 
                  <span class="major">
Pharmacology and Clinical Pharmacology                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2009-01-01">2009</abbr> &#8211; <abbr class="dtend" title="2013-12-31">2013</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
            <div class="position  education vevent vcard" id="63977042">


                <h3 class="summary fn org">
                  
Universit&#xe9; Claude Bernard (Lyon I)                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">European Market Access Diploma</span>, 
                  <span class="major">
European Market Access Procedures                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2011-01-01">2011</abbr> &#8211; <abbr class="dtend" title="2011-12-31">2011</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    

                  <p class="desc details-education" name="activities"><em>Activities and Societies:</em>
The programme follows each step of the life cycle of a drug, integrating market access theory and practice for results you can apply in the real world. Students will acquire the necessary skills to develop and implement a market access plan.                  </p>





            </div>
            <div class="position  education vevent vcard" id="42912608">


                <h3 class="summary fn org">
                  
Temple University                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">Post MSc Fellowship</span>, 
                  <span class="major">
Pharmacoeconomy and Health Outcome                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2009-01-01">2009</abbr> &#8211; <abbr class="dtend" title="2010-12-31">2010</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
            <div class="position  education vevent vcard" id="42912522">


                <h3 class="summary fn org">
                  
Yeditepe &#xdc;niversitesi                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">MSc</span>, 
                  <span class="major">
Pharmacoeconomy and Pharmacoepidemiology                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2008-01-01">2008</abbr> &#8211; <abbr class="dtend" title="2010-12-31">2010</abbr>
                    
                  </p>
              
       
     

                      <p class="desc details-education"><em>Grade:</em>  High Honor</p>


                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
            <div class="position  education vevent vcard" id="42912458">


                <h3 class="summary fn org">
                  
Istanbul University                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">MD</span>, 
                  <span class="major">
Medicine                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2001-01-01">2001</abbr> &#8211; <abbr class="dtend" title="2007-12-31">2007</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
            <div class="position  education vevent vcard" id="43054761">


                <h3 class="summary fn org">
                  
Mimar Sinan G&#xfc;zel Sanatlar &#xdc;niversitesi                  
                </h3>


              <h4 class="details-education">
                
                
                  <span class="major">
Architecture                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="1999-01-01">1999</abbr> &#8211; <abbr class="dtend" title="2001-12-31">2001</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
            <div class="position  education vevent vcard" id="43054857">


                <h3 class="summary fn org">
                  
Sel&#xe7;uk Anadolu Lisesi                  
                </h3>


              <h4 class="details-education">
                
                
                  <span class="major">
High School                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="1992-01-01">1992</abbr> &#8211; <abbr class="dtend" title="1999-12-31">1999</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    
</p>

    






            </div>
        </div>
			   
    </div>
  </div>


              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
            
                

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      








  <div class="section" id="profile-additional" style="display:block">
  <div class="header">
    <h2>Guvenc Kockaya, MD, MSc's Additional Information
    </h2>
  </div>
  <div class="content">
  <dl>



   <dt class="interests" style="display:block">Interests:</dt>
   <dd class="interests" id="interests" style="display:block">
          <p class="">
health economics, health technology assessment, pricing &amp; reimbursement          </p>
   </dd>



    <dt class="honors" style="display:block">Honors and Awards:</dt>
    <dd class="honors" class="last" style="display:block">
          

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    2nd Best European Service Project 2004 &quot;Give a Hand for a World Without Hepatitis B&quot;, European Rotaract Committee<br>
<br>
2nd Best European Service Project 2005 &quot;RotAIDS&quot;, European Rotaract Committee
</p>

    
    </dd>
  </dl>
</div>
</div>

              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
	
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
















<div class="section" id="profile-contact" style="display:block">
  <div class="header">
    
      <h2>Contact Guvenc for:
        
      </h2>
    
	</div>
  <div class="content">
    
        
        
            
          

        
        
        
        <div class="interested">
          <ul>
              <li>career opportunities</li>
              <li>consulting offers</li>
              <li>new ventures</li>
              <li>job inquiries</li>
              <li>expertise requests</li>
              <li>business deals</li>
              <li>reference requests</li>
              <li>getting back in touch</li>
          </ul>
        </div>
        

        
        
      
  </div>
</div>










              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
          

          
            <div class="section view-full-profile">
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


<div class="header">
  
    <h3>View Guvenc Kockaya, MD, MSc&#8217;s full profile to...</h3>
  
</div>
<div class="content">
  <ul>
    <li>See who you and <strong>Guvenc Kockaya, MD, MSc</strong> know in common</li>
    <li>Get introduced to <strong>Guvenc Kockaya, MD, MSc</strong></li>
    <li>Contact <strong>Guvenc Kockaya, MD, MSc</strong> directly</li>
  </ul>
  <p class="btn">
    
        <a class="action btn-action" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dfHO8ItrV_BTL_0P7o4SJRdSf3s7PA64b2wUbD5tRnVt1xr0t0ZUqIgoujj7RAh3ugsc8UmN2rdBG1wqf3LiEYN0aaleJ5OnVkwghF7m-SL&amp;trk=ppro_viewmore" rel="nofollow"><span>View Full Profile</span></a>
      
  </p>
  
</div>


            </div>
          

        </div>
        


        <div id="extra">
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

    
  
      
  
      
  
      
  
      

      
      







          
                
            

          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


      
    
  
      
      

      
        
      





<div class="leo-module mod-action name-search">
  <div class="header"><h3>Name Search:</h3></div>
  <div class="content">
    <p><strong>Search for people you know</strong> from over 225 million professionals already on LinkedIn.</p>
    <form name="searchForm" action="/pub/dir/" method="get">
      <ul>
        
        <li>
        
          <label for="first">First Name</label>
        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736677-22" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _ghostlabel */
          
        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-8736677-22', 'GhostLabel', {});
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
        <input type="text" name="first" id="first" />
        </li>
        
          <li>
          
            <label for="last">Last Name</label>
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-8736677-23" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-8736677-23', 'GhostLabel', {});
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
          <input type="text" name="last" id="last" />
          </li>
        
      </ul>
      <p class="action"><input class="search-go" type="submit" name="search" value="Search"/></p>
      <p class="note"> Example: 
        <strong>
        <a href="http://www.linkedin.com/in/jeffweiner08" tracking="ppro_find_others_rh">Jeff Weiner</a>
        </strong>
      </p>
    </form>
  </div>
</div>






          <div class="modules panel">
          
              

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
 
      
        
      
  




<div class="leo-module mod-util browsemap">
  <div class="header">
    <h3><strong>Viewers of this profile also viewed...</strong></h3>
  </div>

  <div class="content">
    <ul>
   
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/mete-saylan/5/463/939?trk=pub-pbmap">
          
              
          
            
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/2/000/0b7/28c/31f1764.jpg" id="img-defer-id-1-36677" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Mete Saylan">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/mete-saylan/5/463/939?trk=pub-pbmap">Mete Saylan</a>
        
        </strong><br>
        <span class="headline">Senior Market Access Manager at Novartis</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/yal%C3%A7%C4%B1n-kaya/23/46b/1b6?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/4/000/148/16c/064f562.jpg" id="img-defer-id-2-36677" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Yal&#xe7;&#x131;n Kaya">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/yal%C3%A7%C4%B1n-kaya/23/46b/1b6?trk=pub-pbmap">Yal&#xe7;&#x131;n Kaya</a>
        
        </strong><br>
        <span class="headline">Market Access, Government &amp; Public...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/bilge-kanbur/25/67b/4b9?trk=pub-pbmap">
          
              <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Bilge Kanbur">
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/bilge-kanbur/25/67b/4b9?trk=pub-pbmap">Bilge Kanbur</a>
        
        </strong><br>
        <span class="headline">Head of Market Access at Alcon Turkey</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/yeliz-ak/30/a08/a53?trk=pub-pbmap">
          
              <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Yeliz Ak">
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/yeliz-ak/30/a08/a53?trk=pub-pbmap">Yeliz Ak</a>
        
        </strong><br>
        <span class="headline">Pharmaceutical Product Pricing,...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/pinar-ulus/14/180/849?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/8/000/246/02c/2137f53.jpg" id="img-defer-id-3-36678" class="img-defer-hidden img-defer photo" width="40" height="40" alt="PINAR ULUS">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/pinar-ulus/14/180/849?trk=pub-pbmap">PINAR ULUS</a>
        
        </strong><br>
        <span class="headline">Manager Reimbursement and Health...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/beg%C3%BCm-urganc%C4%B1/35/115/267?trk=pub-pbmap">
          
              <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Beg&#xfc;m Urganc&#x131;">
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/beg%C3%BCm-urganc%C4%B1/35/115/267?trk=pub-pbmap">Beg&#xfc;m Urganc&#x131;</a>
        
        </strong><br>
        <span class="headline">Reimbursement and Health Economics...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/aysen-aksel-senturk-msc/31/513/3b?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/3/000/0a9/02d/26c8d3b.jpg" id="img-defer-id-4-36678" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Aysen Aksel Senturk, MSc">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/aysen-aksel-senturk-msc/31/513/3b?trk=pub-pbmap">Aysen Aksel Senturk, MSc</a>
        
        </strong><br>
        <span class="headline">Health Economist &amp; Government Relations...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/000/0b7/182/2c6e2c5.jpg" id="img-defer-id-5-36678" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Albert Wertheimer">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/albert-wertheimer/12/78/526?trk=pub-pbmap">Albert Wertheimer</a>
        
        </strong><br>
        <span class="headline">Professor of Pharmaceutical Economics...</span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/rabia-kahveci/2/599/45b?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/000/056/33e/378627c.jpg" id="img-defer-id-6-36678" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Rabia Kahveci">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/rabia-kahveci/2/599/45b?trk=pub-pbmap">Rabia Kahveci</a>
        
        </strong><br>
        <span class="headline"></span>
      </li>
    


           
           
        
      
        
         
           
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://tr.linkedin.com/pub/gorkem-saka-phd/1/324/797?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/2/000/12a/39e/35b9c44.jpg" id="img-defer-id-7-36678" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Gorkem Saka, PhD">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://tr.linkedin.com/pub/gorkem-saka-phd/1/324/797?trk=pub-pbmap">Gorkem Saka, PhD</a>
        
        </strong><br>
        <span class="headline"></span>
      </li>
    


           
           
        
      
     
    </ul>
  </div>
 </div>



              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


   

            
          </div>
          <div class="ad-block">
              <script type="text/javascript">var dbl_page = 'public_profile';</script>
    	      
              
      
      
      <script type="text/javascript">
      /* <![CDATA[ */
      
        var dbl_src = "http://ad.doubleclick.net/adj/linkedin.dart/" + dbl_page + ";lang=en;tile=1;dcopt=ist;sz=300x250;;" + encodeURIComponent('uprofile=60682068;company=899089;pcntry=tr') + ";s=0;ord=" + Math.random() * 10000000000000000 +"?";
        document.write('<sc' + 'ript src="' + dbl_src + '" type="text/javascript"><\/scr' + 'ipt>');
      /* ]]> */
        </script>
      
      
    

            
          </div>
          
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      

      
        
      



  
    <div class="leo-module mod-util job-search modules panel">
      <div class="header">
        <h3><strong>Jobs you may be interested in:</strong></h3>
      </div>
      <div class="content">
        <ul>
          
            <li>
              <h4>
                <a href="/job/q-sales-head-jobs?trk=pprofile-jserp">
                  Sales Head jobs
                </a>
              </h4>
            </li>
          
            <li>
              <h4>
                <a href="/job/q-author-jobs?trk=pprofile-jserp">
                  Author jobs
                </a>
              </h4>
            </li>
          
            <li>
              <h4>
                <a href="/job/q-medical-advisor-jobs?trk=pprofile-jserp">
                  Medical Advisor jobs
                </a>
              </h4>
            </li>
          
            <li>
              <h4>
                <a href="/job/q-columnist-jobs?trk=pprofile-jserp">
                  Columnist jobs
                </a>
              </h4>
            </li>
          
        </ul>
        <p class="more">
          <a href="http://www.linkedin.com/directory/jobs/?trk=pprofile-more-jobs">
            More Jobs <span> &raquo;</span>
          </a>
        </p>
      </div>
    </div>
  


          
        </div>

  
     
      
    
    
  
    
      
        
      
    
    
  
      
      
      
        
      
    
      
        
          
        
        
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 </div>
</div>
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<script type="text/javascript">LI.Controls.processQueue();</script>
        
      
      
      
        
      
    
    
  

  
      
      
      
        
      
    
      
    
      
        
      
    
    
      
     
      
        
      
    
     
      
        
          
        

        
          

          
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


 
 
 

 
 




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



<div id="footer">
 <div class="wrapper">
 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      

      
        
      





<div id="directory" class="us">
  <h3>
    
    
        LinkedIn member directory - Browse members <a href="/static?key=country_listing">by country</a>
      
    
  </h3>
  <ol type="a" class="primary">
    
      
        <li>
          <a href="/directory/people-a">a</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-b">b</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-c">c</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-d">d</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-e">e</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-f">f</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-g">g</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-h">h</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-i">i</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-j">j</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-k">k</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-l">l</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-m">m</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-n">n</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-o">o</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-p">p</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-q">q</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-r">r</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-s">s</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-t">t</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-u">u</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-v">v</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-w">w</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-x">x</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-y">y</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-z">z</a>
        </li>
      
    
    
      <li>
        
            
            <a href="/directory/people-1" class="callout-trigger nlcl-hovercard-trigger">more</a>
        
      </li>
    
    
  </ol>
    
  </div>

 <p id="terms-of-use">
 By using this site, you agree to LinkedIn's <a rel="nofollow" href="/static?key=user_agreement&trk=ftr_useragre">terms of use</a>. Commercial use of this site without express authorization is prohibited.
 </p>
 <p id="copyright">LinkedIn Corporation &copy; 2013</p>
 <ul id="nav-legal">
 <li><a href="/static?key=user_agreement&amp;trk=hb_ft_userag">User Agreement</a></li>
 <li><a href="/static?key=privacy_policy&amp;trk=hb_ft_priv">Privacy Policy</a></li>
 <li><a href="/legal/cookie-policy">Cookie Policy</a></li>
 <li class="last"><a href="/static?key=copyright_policy&amp;trk=hb_ft_copy">Copyright Policy</a></li>
 </ul>
 </div>
 </div>


      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


  
     
      
    
    
    
    
    
    
    
    
    
  
    
      
        
          
            
                
              
          
        
      
    
    
  <script type="text/javascript">
    LI.define("RUM.urls");
    LI.define("RUM.flags");
    LI.RUM.flags['host-flag'] = "control";
    LI.RUM.urls['rum-track'] = "/lite/rum-track?csrfToken=ajax%3A5300005367096190683";
    LI.RUM.urls['boomerang-bw-img'] = "http://s.c.lnkd.licdn.com/scds/common/u/lib/boomerang/0.9.edge.4ab208445a/img/";
    
    
    
    LI.RUM.serverStartTime = 1379692547.646*1000;
    
    
    LI.RUM.enabled = true;
    YEvent.on(window, 'load', function() {
      YAHOO.util.Get.script(
      
        
            
              
              
                ["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ed29nkjpsa16bhrjq4na16owq-98wkc8drte3f4sgowwihu52bc-cxf4wsvkntx8ipnbh8aw32ci5-bntxs37tllhamgkqo8dp140n4-ej0bu8dhge4a5yggpk9bkobg0-2e50soneky56rf7x4eqnd3iqq&fc=2"]
              
            
          
        
      
    [0]);
    });
  </script>



<script type="text/javascript">
 if ( window.LI && LI.showAllDeferredImg && !LI.imgDeferFoldCheckDone ) { 
 LI.showAllDeferredImg( null, false );
 }
</script>



          

          
            
          
        
      
      
      
      
        
      
    
      
        

        
          <script id="localChrome"></script>
        
      
    
  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      







    <script type="text/javascript">
      var _gaq = _gaq || [];
      _gaq.push(['_setAccount', 'UA-3242811-1']);
      _gaq.push(['_setDomainName', '.linkedin.com']);
      _gaq.push(['_trackPageview', 'nprofile-public-success']);
      _gaq.push(['_setVar', 'guest']);
      
      
      YEvent.on( window, 'load', function() {
        YAHOO.util.Get.script("http://www.google-analytics.com/ga.js");
      });
    </script>
  

  





<script type="text/javascript">/* <![CDATA[ */
(function() {

  var bcookie = escape( LI.readCookie("bcookie") ),
    newTrkInfo = '60682068,' + document.referrer.substr(0,128),
    alias_secure = 'https://www.linkedin.com/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_public_jsbeacon&trkInfo=REPLACEME',
    alias_normal = '/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_public_jsbeacon&trkInfo=REPLACEME',
    is_secure = false,
    url = (is_secure) ? alias_secure : alias_normal;

  url = url.replace("REPLACEME", newTrkInfo);

  if (bcookie) {
    if(window.$ && $.ajax){
      $.ajax(url);
    } else {
      YAHOO.util.Connect.asyncRequest( 'get', url, {} );
    }
  }

})();
/* ]]> */</script>

  
      
        
      
      
      
      
        
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
      
      
      
      
      <script type="text/javascript">
        
          
      
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
        LI_WCT([
        
          
            
              "control-http-12248-8736662-1",
            
          
        
          
            
              "control-http-12248-8736664-2",
            
          
        
          
            
              "control-http-12248-8736664-3",
            
          
        
          
            
              "control-http-12248-8736665-4",
            
          
        
          
            
              "control-http-12248-8736665-5",
            
          
        
          
            
              "control-http-12248-8736665-6",
            
          
        
          
            
              "control-http-12248-8736666-7",
            
          
        
          
            
              "control-http-12248-8736666-8",
            
          
        
          
            
              "control-http-12248-8736667-9",
            
          
        
          
            
              "control-http-12248-8736667-10",
            
          
        
          
            
              "control-http-12248-8736667-11",
            
          
        
          
            
              "control-http-12248-8736668-12",
            
          
        
          
            
              "control-http-12248-8736668-13",
            
          
        
          
            
              "control-http-12248-8736670-14",
            
          
        
          
            
              "control-http-12248-8736670-15",
            
          
        
          
            
              "control-http-12248-8736671-16",
            
          
        
          
            
              "control-http-12248-8736671-17",
            
          
        
          
            
              "control-http-12248-8736672-18",
            
          
        
          
            
              "control-http-12248-8736673-19",
            
          
        
          
            
              "control-http-12248-8736674-20",
            
          
        
          
            
              "control-http-12248-8736674-21",
            
          
        
          
            
              "control-http-12248-8736677-22",
            
          
        
          
            
              "control-http-12248-8736677-23",
            
          
        
        ]);
      
    
          
            
          
        
        
      </script>
      
      
      
      
    
      
        

        
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



<script type="text/javascript">LI.Controls.processQueue();</script>





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


<script type="text/javascript">
  LI.define('Tracking.Quantcast');
  LI.Tracking.Quantcast = function() {
    _qoptions = { qacct:"p-b3sGjMtCFrexE" };
    YAHOO.util.Get.script( 'http://edge.quantserve.com/quant.js' );
  };
  YEvent.on( window, 'load', LI.Tracking.Quantcast);
</script>
<noscript>
  <a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" height="1" width="1" alt=""/></a>
</noscript>

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


<script type="text/javascript">
  LI.define('Tracking.Comscore');
  LI.Tracking.Comscore = function() {
    YAHOO.util.Get.script( 'http://b.scorecardresearch.com/beacon.js', {
      onSuccess: function() {
        COMSCORE.beacon({ c1:2, c2:6402952, c3:"", c4:"", c5:"", c6:"", c15:"" });
      }
    });
  };
  YEvent.on( window, 'load', LI.Tracking.Comscore);
</script>
<noscript>
  
      <img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt="" />
    
</noscript>

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    
<script type="text/javascript">
  YEvent.on( window, 'load', function() {
    (function () {
      var protocol = 'http:';
      var d = new Image(1, 1);
      d.onerror = d.onload = function () { d.onerror = d.onload = null; };    
      d.src = [
        protocol,
        "//secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&si=", 
        escape(window.location.href), "&rp=", 
        escape(document.referrer),   
        "&ts=compact&rnd=", 
        (new Date()).getTime()
      ].join('');
    })();
  });
</script>
<noscript>
  
      <img src="http://secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&ts=noscript"
    width="1" height="1" alt="" style="display:none"/>
    
</noscript>


 
 



 </body>
</html>

          
        
      
      
      
      
        
      
    
    














